Analyst Research Report Snapshot

Title:

GlaxoSmithKline Plc

Price:

$175.00

Provider:

MarketLine (a Datamonitor Company)

Date:

12 Mar 2014

Pages:

70

Type:

AcrobatPDF

Companies referenced:

GSK.L

Available for Immediate Download
Summary:

GlaxoSmithKline Plc - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs - A study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis - An in-depth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments - Intelligence on GlaxoSmithKline Plc’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: GlaxoSmithKline Plc (GSK or 'the company') is a leading global provider of pharmaceutical and consumer health-related products. The company operates in more than 100 countries and its products are sold in about 150 countries. GSK is headquartered in Brentford, the UK, and employed 99,488 people as on December 31, 2012. The company recorded revenues of £26,431 million (approximately $41,885.2 million) during the financial year ended December 2012 (FY2012), a decrease of 3.5% compared with FY2011. The operating profit of the company was £7,392 million (approximately $11,714.1 million) in FY2012, a decrease of 5.3% compared with FY2011. The net profit was £4,565 million (approximately $7,234.2 million) in FY2012, a decrease of 13.2% compared with FY2011. Reasons to Purchase: - Gain understanding of GlaxoSmithKline Plc and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess GlaxoSmithKline Plc as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on GlaxoSmithKline Plc’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.